CATALYST PHARMACEUTICALS INC

Angel Pharma’s 2026 merger with Catalyst: insider sales, regulatory compliance, and strategic synergies that boost rare‑disease pipeline speed and investor confidence.

Insider buying at Catalyst Pharmaceuticals signals management confidence ahead of earnings—read how Russo Gregg’s 687‑share purchase and December buying spree could boost stock price.